Correction: Multiple functions of human T cells generated by experimental malaria challenge

Correction: Multiple functions of human T cells generated by experimental malaria challenge

Bibliográfalaš dieđut
Váldodahkkit:	Todryk, S, Walther, M, Bejon, P, Hutchings, C, Thompson, F, Urban, B, Porter, D, Hill, A
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2011

Geahča maid

Multiple functions of human T cells generated by experimental malaria challenge
Dahkki: Todryk, S, et al.
Almmustuhtton: (2009)

Multiple functions of human T cells generated by experimental malaria challenge.
Dahkki: Todryk, S, et al.
Almmustuhtton: (2009)

Measuring malaria memory
Dahkki: Todryk, S, et al.
Almmustuhtton: (2008)

Correction: Malaria vaccine development: Lessons from the field
Dahkki: Todryk, S, et al.
Almmustuhtton: (2011)

A human phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
Dahkki: Porter, D, et al.
Almmustuhtton: (2011)

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine.
Dahkki: Porter, D, et al.
Almmustuhtton: (2011)

Malaria vaccine development: lessons from the field.
Dahkki: Todryk, S, et al.
Almmustuhtton: (2009)

Comparing human T cell and NK cell responses in viral-based malaria vaccine trials.
Dahkki: Berthoud, T, et al.
Almmustuhtton: (2009)

Correction: Correlation of Memory T Cell Responses against TRAP with Protection from Clinical Malaria, and CD4 CD25 T Cells with Susceptibility in Kenyans.
Dahkki: Stephen M. Todryk, et al.
Almmustuhtton: (2011-01-01)

Malaria vaccines: the stage we are at.
Dahkki: Todryk, S, et al.
Almmustuhtton: (2007)

Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.
Dahkki: Todryk, S, et al.
Almmustuhtton: (2008)

Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4^+ CD25 ^high T cells with susceptibility in Kenyans
Dahkki: Todryk, S, et al.
Almmustuhtton: (2008)

Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infection.
Dahkki: Douglas, A, et al.
Almmustuhtton: (2013)

Regulatory T cells limit the cellular response to CS and TRAP encoding candidate malaria vaccines in humans [MIM-SD-8756]
Dahkki: Dunachie, S, et al.
Almmustuhtton: (2005)

Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.
Dahkki: Stephen M Todryk, et al.
Almmustuhtton: (2008-04-01)

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
Dahkki: Keating, S, et al.
Almmustuhtton: (2005)

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.
Dahkki: Bejon, P, et al.
Almmustuhtton: (2006)

Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial.
Dahkki: Fiona M. Thompson, et al.
Almmustuhtton: (2011-01-01)

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.
Dahkki: Thompson, F, et al.
Almmustuhtton: (2008)

The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming.
Dahkki: Todryk, S, et al.
Almmustuhtton: (2009)

Safety, immunogenicity and efficacy studies of candidate malaria vaccines FP9 and MVA encoding ME-TRAP in Kenyan children [MIM-PB-224908]
Dahkki: Bejon, P, et al.
Almmustuhtton: (2005)

Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites.
Dahkki: Bejon, P, et al.
Almmustuhtton: (2005)

The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming (vol 128, pg 83, 2009)
Dahkki: Todryk, S, et al.
Almmustuhtton: (2011)

MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines.
Dahkki: Berthoud, T, et al.
Almmustuhtton: (2009)

Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.
Dahkki: Hutchings, C, et al.
Almmustuhtton: (2007)

MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines (vol 340, pg 33, 2009)
Dahkki: Berthoud, T, et al.
Almmustuhtton: (2011)

Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials.
Dahkki: Andrews, L, et al.
Almmustuhtton: (2005)

Viral vector vaccines make memory T cells against malaria.
Dahkki: Reyes-Sandoval, A, et al.
Almmustuhtton: (2007)

Corrigendum to "MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines" [J. Immunol. Methods 340 (2009) 33-41]
Dahkki: Berthoud, T, et al.
Almmustuhtton: (2011)

Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: experiences and perceptions of study participants in a malaria Challenge study in Kenya
Dahkki: Njue, M, et al.
Almmustuhtton: (2018)

Blood-stage challenge for malaria vaccine efficacy trials: a pilot study with discussion of safety and potential value.
Dahkki: Sanderson, F, et al.
Almmustuhtton: (2008)

Corrigendum to "MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines" [J. Immunol. Methods 340 (2009) 33-41] (DOI:10.1016/j.jim.2008.09.021)
Dahkki: Berthoud, T, et al.
Almmustuhtton: (2011)

Correction: Interactions between Age and ITN Use Determine the Risk of Febrile Malaria in Children.
Dahkki: Philip Bejon, et al.
Almmustuhtton: (2011-01-01)

Correction: Quantitative PCR Evaluation of Cellular Immune Responses in Kenyan Children Vaccinated with a Candidate Malaria Vaccine.
Dahkki: Jedidah Mwacharo, et al.
Almmustuhtton: (2011-01-01)

Malaria.
Dahkki: Maitland, K, et al.
Almmustuhtton: (2003)

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.
Dahkki: Fiona M Thompson, et al.
Almmustuhtton: (2008-01-01)

Steps towards a malaria vaccine
Dahkki: Bejon, P
Almmustuhtton: (2005)

TRAP-based vectored vaccines are more immunogenic and protective than CSP-based vectors: Correlation of efficacy with long-lived memory T cells [MIM-AH-359251]
Dahkki: Dunachie, S, et al.
Almmustuhtton: (2005)

Potency assays for novel T-cell-inducing vaccines against malaria.
Dahkki: Reyes-Sandoval, A, et al.
Almmustuhtton: (2009)

Helminth infection and eosinophilia and the risk of Plasmodium falciparum malaria in 1- to 6-year-old children in a malaria endemic area
Dahkki: Bejon, P, et al.
Almmustuhtton: (2008)